Lukas Dow

Lukas Dow

Cornell University

H-index: 43

North America-United States

About Lukas Dow

Lukas Dow, With an exceptional h-index of 43 and a recent h-index of 37 (since 2020), a distinguished researcher at Cornell University,

His recent articles reflect a diverse array of research interests and contributions to the field:

The GPR52-MCAM axis as a novel regulatory mechanism of breast cancer cell clustering and metastatic potential

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibition

Generation of precision preclinical cancer models using regulated in vivo base editing

Abstract B080: Mutant-selective KRASG12D(ON) inhibitor suppresses proliferation in vitro and tumor growth in vivo of KrasG12D GEMM-derived PDAC organoids

Serine Supports Epithelial and Immune Cell Function in Colitis

Adding new dimensions to 3D cancer models

Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Lukas Dow Information

University

Position

Weill Cornell Medicine

Citations(all)

9916

Citations(since 2020)

6411

Cited By

5835

hIndex(all)

43

hIndex(since 2020)

37

i10Index(all)

61

i10Index(since 2020)

60

Email

University Profile Page

Cornell University

Google Scholar

View Google Scholar Profile

Top articles of Lukas Dow

Title

Journal

Author(s)

Publication Date

The GPR52-MCAM axis as a novel regulatory mechanism of breast cancer cell clustering and metastatic potential

Cancer Research

Sarah Z Hanif

CheukMan C Au

Ingrid Torregroza

Bhavneet Bhinder

Lukas Dow

...

2024/3/22

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibition

M Laura Martin

Rachel Martini

Sarah Ackermann

Colin Tang

Marvel Tranquille

...

2024/1/31

Generation of precision preclinical cancer models using regulated in vivo base editing

Nature Biotechnology

Alyna Katti

Adrián Vega-Pérez

Miguel Foronda

Jill Zimmerman

Maria Paz Zafra

...

2023/8/10

Abstract B080: Mutant-selective KRASG12D(ON) inhibitor suppresses proliferation in vitro and tumor growth in vivo of KrasG12D GEMM-derived PDAC organoids

Cancer Research

Mark P Labrecque

Lingyan Jiang

Nicole Nasholm

Biswadeep Nayak

Xinxing Yu

...

2024/1/16

Serine Supports Epithelial and Immune Cell Function in Colitis

The American Journal of Pathology

Ji Dong K Bai

Suchandrima Saha

Michael Wood

Bo Chen

Jinyu Li

...

2024/2/28

Adding new dimensions to 3D cancer models

Cancer Research

Kevan Chu

Lukas E Dow

2024/2/9

Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma

Cancer Discovery

Zhuxuan Li

Xueqian Zhuang

Chun-Hao Pan

Yan Yan

Rohit Thummalapalli

...

2024/2/8

Abstract NG10: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Cancer Research

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Alexander Martinez-Fundichely

...

2023/4/4

Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2

Science translational medicine

Priya Bhardwaj

Neil M Iyengar

Heba Zahid

Katharine M Carter

Dong Jun Byun

...

2023/2/22

Solid tumor growth depends on an intricate equilibrium of malignant cell states

bioRxiv

Stefan R Torborg

Olivera Grbovic-Huezo

Anupriya Singhal

Matilda Holm

Katherine Wu

...

2023

Oncogenic context shapes the fitness landscape of tumor suppression

Nature Communications

Lily M Blair

Joseph M Juan

Lafia Sebastian

Vy B Tran

Wensheng Nie

...

2023/10/12

Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasis

bioRxiv

Leona A Nease

Kellsey P Church

Ines Delclaux

Shino Murakami

Maider A Amiama

...

2023

How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research

Francisco J Sánchez Rivera

Lukas E Dow

2023/7/24

Novel genetically engineered mouse models for clear cell renal cell carcinoma

Scientific Reports

Johannes C van der Mijn

Kristian B Laursen

Leiping Fu

Francesca Khani

Lukas E Dow

...

2023/5/22

Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants

Nature biotechnology

Francisco J Sánchez-Rivera

Bianca J Diaz

Edward R Kastenhuber

Henri Schmidt

Alyna Katti

...

2022/6

Abstract B026: Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Cancer Research

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Alexander Martinez-Fundichely

...

2022/12/1

Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival

Bmc Genomics

Jonathan W Villanueva

Lawrence Kwong

Teng Han

Salvador Alonso Martinez

Michael T Shanahan

...

2022/12/1

Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

Science

Fanying Tang

Duo Xu

Shangqian Wang

Chen Khuan Wong

Alexander Martinez-Fundichely

...

2022/5/27

CRISPR in cancer biology and therapy

Alyna Katti

Bianca J Diaz

Christina M Caragine

Neville E Sanjana

Lukas E Dow

2022/5

Rapid generation of precision preclinical cancer models using regulatable in vivo base editing

bioRxiv

Alyna Katti

Miguel Foronda

Jill Zimmerman

Maria Paz Zafra

Sukanya Goswami

...

2022/8/4

See List of Professors in Lukas Dow University(Cornell University)